JAPANESE VERSION COMPASSIONATE USE STUDY OF ATEZOLIZUMAB IN PATIENTS WITH LOCALLY ADVANCED OR METASTATIC UROTHELIAL CANCER AFTER FAILURE WITH PLATINUM-CONTAINING CHEMOTHERAPY
Phase of Trial: Phase III
Latest Information Update: 15 May 2017
At a glance
- Drugs Atezolizumab (Primary)
- Indications Urogenital cancer
- Focus Adverse reactions; Therapeutic Use
- Sponsors Chugai Pharmaceutical
- 12 May 2017 Status changed from recruiting to suspended.
- 21 Dec 2016 Status changed from not yet recruiting to recruiting.
- 16 Nov 2016 New trial record